Biogen Inc (BIIB)

Index:

Nasdaq 100

$ 196.24
   
  • Change Today:
    $-0.15
  • 52 Week High: $201.89
  • 52 Week Low: $122.68
  • Currency: US Dollars
  • Shares Issued: 146.80m
  • Volume: 41,120
  • Market Cap: $28,808m
  • RiskGrade: 259

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Continuing Operations          
Revenue 9,890.60 9,675.90 9,835.60 10,173.40 10,981.70
Operating Profit/(Loss) 1,556.50 1,906.00 1,296.80 3,591.80 2,840.70
Profit Before Tax 1,556.50 1,906.00 1,296.80 3,591.80 1,779.50
Profit After Tax 1,292.90 1,632.20 1,161.50 2,961.60 1,727.00
           
Earnings per Share - Basic 883.00¢ 1,121.00¢ 802.00¢ 2,096.00¢ 1,044.00¢
Earnings per Share - Adjusted 883.00¢ 1,121.00¢ 802.00¢ 2,096.00¢ 1,044.00¢
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Assets          
Non-Current Assets          
Property, Plant & Equipment 3,320.80 3,537.70 3,729.70 3,702.50 4,996.00
Intangible Assets 15,669.60 16,170.10 14,582.20 7,599.10 5,003.00
Other Non-Current Assets 1,475.00 884.70 1,673.60 3,461.30 874.00
  20,465.40 20,592.50 19,985.50 14,762.90 10,873.00
Current Assets          
Inventories 2,168.10 2,460.50 2,527.40 1,344.40 1,504.00
Cash at Bank & in Hand 3,008.50 2,375.00 1,049.90 3,419.30 459.00
Other Current Assets 3,797.50 2,621.30 3,282.00 5,027.50 2,683.00
  8,974.10 7,456.80 6,859.30 9,791.20 4,646.00
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 29,439.50 28,049.30 26,844.80 24,554.10 15,519.00
Current Liabilities          
Borrowings n/a 1,748.60 150.00 n/a 747.00
Other Current Liabilities 3,349.40 3,780.20 3,284.30 3,272.80 2,224.00
           
Current Liabilities 3,349.40 5,528.80 3,434.30 3,272.80 2,971.00
           
Net Current Assets c5,624.70 c1,928.00 c3,425.00 c6,518.40 c1,675.00
           
Borrowings 6,577.20 4,881.70 7,188.20 6,614.00 4,412.00
Other Non-Current Liabilities 1,256.10 922.80 1,422.90 1,278.90 2,348.00
Non-Current Liabilities 7,833.30 5,804.50 8,611.10 7,892.90 6,760.00
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 11,182.70 11,333.30 12,045.40 11,165.70 9,731.00
           
Net Assets 18,256.80 16,716.00 14,799.40 13,388.40 5,788.00
           
Shareholders Funds 18,256.80 16,716.00 14,799.40 13,397.90 5,704.00
           
Minority Interests/Other Equity n/a n/a n/a (9.50) 84.00
Total Equity 18,256.80 16,716.00 14,799.40 13,388.40 5,788.00
Cash Flow 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Net Cash Flow From Operating Activities 2,204.60 2,875.50 1,547.20 1,384.30 3,639.90
Net Cash Flow from Investing Activities (1,371.10) (799.20) (4,101.00) 1,576.60 (563.70)
Net Cash Flow from Financing Activities (301.90) (683.50) 149.30 (1,747.30) (2,086.20)
Net Increase/Decrease In Cash 531.60 1,392.80 (2,404.50) 1,213.60 990.00
Ratios - based on IFRS 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Continuing Operations          
PE Ratio - Adjusted 19.9 13.6 32.3 13.2 23.0
PEG - Adjusted n/a 0.3 n/a 0.1 n/a
Earnings per Share Growth - Adjusted -21% 40% -62% 101% -58%
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 6,737.47¢ 6,591.21¢ 6,700.00¢ 6,930.11¢ 7,480.72¢
Pre-Tax Profit per Share 1,060.29¢ 1,298.37¢ 883.38¢ 2,446.73¢ 1,212.19¢
Operating Margin 15.74% 19.70% 13.18% 35.31% 25.87%
Return on Capital Employed 16.98% 26.56% 17.16% 28.96% 29.94%
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 1,501.77¢ 1,958.79¢ 1,053.95¢ 942.98¢ 2,479.50¢
Cash Incr/Decr per Share 362.12¢ 948.77¢ (1,637.94¢) 826.70¢ 674.39¢
Net Asset Value per Share (exc. Intangibles) 1,762.40¢ 371.87¢ 147.96¢ 3,943.66¢ 534.74¢
Net Gearing 19.55% 25.46% 42.49% 23.84% 82.40%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page